Skip to main content
News

News  Circular Letter: DCP 22-07-113

8/17/2022
  • Drug Control Program
  • Prescription Monitoring Program

The purpose of this circular letter is to inform Massachusetts pharmacies of the release of a new version of the Data Submission Guide for Dispensers, Version 5.0.  The PMP Clearinghouse is upgrading to the ASAP 4.2A format, which contains several new data fields.  Version 5.0 provides reporting guidance for these new data fields, reporting clarifications for several existing fields, and guidance for the reporting of dispensed opioid antagonists (Naloxone) required by MGL Chapter 94C Section19B.

Pharmacies should be prepared to comply with these changes no later than October 1, 2022.

Circular Letter

DCP 22-07-113 – Changes to Prescription Monitoring Program (PMP) Reporting Requirements

  • Drug Control Program 

    We promote access to safe and effective pharmaceutical care services in Massachusetts. We work to protect consumers against fraud, deception, and unsafe practices in the distribution, handling, and use of pharmaceuticals and medical devices.

  • Prescription Monitoring Program 

    The PMP tracks statewide Schedule II-V prescriptions. With this system in place, we can give practitioners the tools they need to make the best clinical decisions.

    • Help Us Improve Mass.gov  with your feedback

    Please do not include personal or contact information.
    Feedback